Across TCGA pan-cancer cohorts, LINC00029 RNA differs between tumor and matched normal tissue in 3 of 18 cancer types tested, making tumor–normal expression one of LINC00029’s most consistent transcriptional readouts.
The strongest signal is observed in lung squamous cell carcinoma (LUSC), where LINC00029 RNA is more highly expressed in tumor relative to normal tissue. In most cancer types LINC00029 is over-expressed in tumor.
LUSC, CHOL, and HNSC are the cancer types where LINC00029 tumor–normal differential expression is most reproducible.